Valiant Laboratories Limited — QIP/Rights/Pref., 15-07-2025: Rights Issue

Valiant Labs is conducting a Rights Issue, offering shareholders an opportunity to increase their stake. Eligible investors can subscribe to new equity shares at ₹75 each, with an entitlement ratio of 1 Rights Share for every 4 shares held as of the July 19, 2025 Record Date. This rights issue is valued at ₹81.47 Cr. For existing shareholders, participating helps maintain their ownership percentage. Not subscribing could lead to a dilution of their stake as the total number of outstanding shares will increase significantly post-issue, assuming full subscription.